Monicit, Ritchel M.
HRN: 24-13-82 Sex: FemalePatient Encounter
Audit Details
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
11/28/2023
METRONIDAZOLE 500MG (TAB)
11/28/2023
12/05/2023
PO
500mg
Q8hrs
SP NSVDelivery; PROM; MSAF
Waiting Final Action
Indication: Prophylaxis Type of Infection: Reproductive Tract Compliance to guidelines: Compliant To Guidelines
Initial appropriateness: Yes
Final appropriateness: Yes
Overall appropriateness: Yes